Whole brain irradiation and intrathecal Methotrexate in the treatment of solid tumor leptomeningeal metastases — A Southwest Oncology Group study

Journal of Neuro-Oncology

Volumn 6, Issue 2, 1988, Pages 107-112

  Sause, William T ^a   Crowley, John ^b,g   Eyre, Harmon J ^a   Rivkin, Saul E ^c   Pugh, Reginald P ^d   Quagliana, Joseph M ^e   Taylor, Sarah A ^f   Molnar, Beverly ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^c Puget Sound Oncology Consortium ^*  (United States)

^d Education & Research ^*  (United States)

^e Humana Hospital Sunrise ^*  (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g Southwest Oncology Group   (United States)

Author keywords

intrathecal methotrexate; leptomeningeal carcinomatosis; whole brain irradiation

Indexed keywords

CORTICOSTEROID; FOLINATE CALCIUM; METHOTREXATE;

BRAIN RADIATION; CLINICAL ARTICLE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MENINX METASTASIS;

COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; METHOTREXATE; MIDDLE AGE;

EID: 0023695405     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/BF02327385     Document Type: Article

References (13)

1. Infiltration of the leptomeninges by systemic cancer — A clinical and pathologic study
2. Meningeal carcinomatosis in breast cancer
3. Meningeal carcinomatosis — clinical manifestations
4. Meningeal carcinomatosis
5. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis
6. Combination intraventricular chemotherapy for meningeal neoplasia
7. Diagnosis and treatment of leptomeningeal metastases from solid tumor: Experience with 90 patients
8. Experience with the subcutaneous cerebrospinal-fluid reservoir — Preliminary report of 60 cases
9. Current status of intrathecal chemotherapy for human meingeal noeplasms
10. Methotrexate — Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections
11. Treatment of malignant meningeal disease with intrathecal ThioTEPA — A Phase II study
12. Miningeal leukemia — control versus cure
13. Combination intrathecal therapy for meningeal leukemia — Two versus three drugs